RIMONABANT

---

Acomplia Active molecule : Rimonabant which is anorexigen inhibitor of type I cannabinoid receptors (receptors CBI). These receptors are involved in the regulation of anger and in the metabolism of glucose and lipids. Acomplia is a drug used in the treatment of obese or overweight patients, or patients affected by type 2 diabetes.

---

Size: 4992px × 3327px
Photo credit: © B. BOISSONNET / BSIP / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: 2, adult, adult-onset, antagonist, antagonists, anti-diabetic, anti-diabetics, antidiabetic, background, backgrounds, box, boxes, cannabinoid, detachable, detached, diabetes, diabetic, diabetics, drug, drugs, embonpoint, ii, inhibit, inhibiting, inhibition, inhibitor, insulin-dependant, insulin-resistant, life, lifes, maturity-onset, medical, medication, medicinal, medicine, medicines, mellitus, obese, obesity, oral, overweight, plain, plumpness, receptor, receptors, rimonabant, stoutness, sugar, therapeutic, therapeutical, treat, treatment, treatments, type